BOT 1.43% 34.5¢ botanix pharmaceuticals ltd

boitech 500k market cap osteo/athritis, page-33

  1. 7,746 Posts.
    Their are a lot of directors owed fees, but the fees seem reasonable for 2years. About $180k and they have agreed to convert 30% of that debt to shares @5c and rollover the rest until we they have cash to pay them after the cr.

    BNE looks interesting.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.